Bone marrow samples from patients with AML (excluding patients with acute promyelocytic leukemia) were analyzed by flow cytometry between ... are summarized in Table 1. Of note, in our cohort ...

Targeting Molecular Measurable Residual Disease and Low-Blast Relapse in AML With Venetoclax and Low-Dose Cytarabine ... An overview over treatment flow and stratification in AML2012 and details of ...

LAP assessment was performed in collaboration with the Dutch-Belgian MRD flow cytometry ... Table 2. Univariate and Multivariate Cox Regression Analysis of Relapse Incidence for Various Prognostic ...

Flow Cytometry Indicates Treatment Response in AML For children with acute myeloid leukemia (AML), minimal residual disease (MRD) activity, as measured using flow cytometry, is a good indicator of ...

for the development of a flow cytometry method for the detection and quantification of human Equilibrative Nucleoside Transporter (hENT1) in patients suffering from Acute Myeloid Leukaemia (AML). The ...

Wallace, a flow cytometry expert, and Elizabeth A. Griffiths, a physician who treats patients with AML. This research, which has potential application to other hematological neoplasms in addition ...

A group from the Shanghai Jiao Tong University School of Medicine has outlined a protocol for the tissue-resident myeloid populations in mouse tissues using flow cytometry. The protocol builds on ...

will shed light on this specific disease form. Antoine Pacheco, Platform Manager for Clinical Instrumentation at Beckman Coulter, will conduct another session from the laboratory, demonstrating the ...

CD7 expression is associated with poorer outcomes in patients with newly diagnosed acute myeloid leukemia (AML), according to a study published online April 11 in the British Journal of Haematology.

Researchers have developed the first computer machine-learning model to accurately predict which patients diagnosed with acute myelogenous leukemia, or AML ... data from flow cytometry, a widely ...